Lead Discovery Siena is Sponsor of the 11th EWDD. The workshop will be held in Certosa di Pontignano at the Conference Center of the University of Siena.
First in this kind, the European Workshop in Drug Design has always been a unique opportunity for graduate students, postdocs and scientists from both Academia and Pharma Industry to celebrate computer-aided drug design and discovery in an exciting and collaborative environment, looking at an impressive sight of the city of Siena from a monastic complex in the heart of the Chianti and Tuscany, and participating to highly interactive hands-on case studies.
LDS is pleased to support this workshop which offers an updated view on most recent modelling techniques and approaches together with the opportunity to meet representatives from both university and pharma industries. LDS will be present during the event and available to talk about the available range of research services and its drug discovery programmes.
On May 21-26, 2017
Maurizio Botta, LDS CEO, was invited to the annual Evening for Science and Society in the Netherlands.
He was personally welcomed by the Secretary of State for Education as the special guest of the event. Every year the event hosts the prestigious Huibregtsen Award for the best academic scientist of the Netherlands during an impressive gala diner in the medieval Hall of the Knights, the official throne hall of the governmental see of the Kingdom of the Netherlands. The event promotes the interaction between science and society by inviting a selection of some of the most important academic scientist of the Netherlands and mixing them up with political decision makers, captains of industry and representatives of important institutions.
Maurizio Botta was honoured to participate and to be at the table with some of the key people involved in the First Health group, which actually sponsors the research on DDX3 inhibitors also involving LDS.
On the group photo above we see Prof. Maurizio Botta next to Mickey Huibregtsen (L), the president of the First Health United Foundation and Maurice de Hond (R), who together with Huibregtsen is a board member of both the First Health United Foundation, as well as the First Health Capital investment fund. On the far left and right we see Alessia Tarditi, the scientific director-, and Jan Willem Bakker, the general manager of First Health Pharmaceuticals.
The Huibregtsen Award of 2016 went to Prof. Dr. Ronald Hanson for his groundbreaking research in quantum physics, where he investigated the capabilities of particles to communicate at distance. On behalf of Mickey Huibregtsen himself and Professor Maurizio Botta we congratulate Professor Hanson with his admirable achievements.
We are proud to announce the participation of Lead Discovery Siena at the BIO USA 2016 convention which will be held in San Francisco, CA, USA, from 6th to 9th June 2016.
The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
Through attending the BIO International Convention LDS benefits from accessing to global biotech and pharma leaders via BIO One-on-One Partnering, exposure to industry though-leaders with over 1,500 education sessions at your fingertips, and unparalleled networking opportunities with 16,000+ attendees from 76 countries.
Our delegates are hosted at Italy Pavilion 2529.
Lead Discovery is Sponsor of the 6th EWDSy (www.ewdsy.it). The workshop is held in Certosa di Pontignano at the Conference Center of the University of Siena, in May 15-19 2016.
The aim of this unique event is to provide a fertile ground for young chemists to share and exchange knowledge. These topics are covered by lectures of cutting-edge researchers in the mornings and dedicated sessions in the afternoon. There is also the possibility to attend to short talks from promising young researchers and shotgun presentations from selected posters.
The 2016 workshop is focused on: Novel Synthetic Procedures in Medicinal Chemistry, Neglected Diseases, HIV Research, and ADMET. All these subjects are strictly related to LDS research activities. The event provides a great opportunity to LDS to meet researchers from Universities and Pharmaceutical Industries and to get an update on most recent advances in the field